Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists.

Journal of the neurological sciences - 15 Jan 2017

Xu Shaoqing, Liu Jiujiang, Yang Xiaodong, Qian Yiwei, Xiao Qin

Abstract excerpt

Dopamine agonists (DAs) play important roles in the treatment of Parkinson's disease (PD). Currently, it is thought that genetic variations in the genes encoding dopamine receptors (DR) are important factors in determining inter-individual variability in drug responses. To investigate the association between Dopamine receptor D type 2 (DRD2) dinucleotide short tandem repeat (CAn-STR) and Dopamine receptor D type...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzothiazoles
Share to Dinucleotide Repeats

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Agonists

Share to Glycine

Share to Parkinson Disease

Share to Receptors, Dopamine D2

Share to Receptors, Dopamine D3

Share to Serine

Source

Identifiers

PMID: 27817855
DOI: 10.1016/j.jns.2016.08.005

Genes

DRD3
DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists.PMID 27817855Read ↗

Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.Semantic proximity Read ↗

Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy.Semantic proximity Read ↗

Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.Semantic proximity Read ↗

Genetic variations in catechol-O-methyltransferase gene are associated with levodopa response variability in Chinese patients with Parkinson's disease.Semantic proximity Read ↗

Dopamine receptor gene polymorphisms in Guangzhou Hans.Semantic proximity Read ↗

Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.Semantic proximity Read ↗

Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.Semantic proximity Read ↗

Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.Semantic proximity Read ↗

The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's diseaseSemantic proximity Read ↗

Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.Semantic proximity Read ↗

Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.Semantic proximity Read ↗

Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.